Research programme: sterile injectables - Endo, Inc./Nevakar
Alternative Names: NVK 003; NVK 004; NVK 005; NVK 014; NVK 019Latest Information Update: 27 Apr 2024
At a glance
- Originator Nevakar
- Developer Endo, Inc.; Nevakar
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer